12 West Capital Management LP Buys 4, Sells 1 in 1st Quarter

Author's Avatar
insider
May 18, 2022
Article's Main Image

12 West Capital Management LP recently filed their 13F report for the first quarter of 2022, which ended on 2022-03-31.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

90 PARK AVENUE NEW YORK, NY 10016

As of the latest 13F report, the guru’s equity portfolio contained 22 stocks valued at a total of $1,645,000,000. The top holdings were GDS(17.51%), TXG(11.65%), and PCOR(11.30%).

According to GuruFocus data, these were 12 West Capital Management LP’s top five trades of the quarter.

Roblox Corp


12 West Capital Management LP reduced their investment in NYSE:RBLX by 2,302,000 shares. The trade had a 10.54% impact on the equity portfolio. During the quarter, the stock traded for an average price of $60.47.

On 05/18/2022, Roblox Corp traded for a price of $31.94 per share and a market cap of $18,946,598,000. The stock has returned -54.70% over the past year.

GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 1 out of 10.

In terms of valuation, Roblox Corp has a price-book ratio of 35.46, a EV-to-Ebitda ratio of -41.96 and a price-sales ratio of 9.41.

Sea Ltd


The guru established a new position worth 827,900 shares in NYSE:SE, giving the stock a 6.03% weight in the equity portfolio. Shares traded for an average price of $141.27 during the quarter.

On 05/18/2022, Sea Ltd traded for a price of $80.21 per share and a market cap of $44,896,581,000. The stock has returned -67.54% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 3 out of 10.

In terms of valuation, Sea Ltd has a price-book ratio of 6.06, a EV-to-Ebitda ratio of -24.59 and a price-sales ratio of 4.30.

The price-to-GF Value ratio is 0.24, earning the stock a GF Value rank of 2.

Procore Technologies Inc


During the quarter, 12 West Capital Management LP bought 1,095,000 shares of NYSE:PCOR for a total holding of 3,208,211. The trade had a 3.86% impact on the equity portfolio. During the quarter, the stock traded for an average price of $63.65.

On 05/18/2022, Procore Technologies Inc traded for a price of $43.48 per share and a market cap of $5,894,319,000. The stock has returned 0.00% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 1 out of 10.

In terms of valuation, Procore Technologies Inc has a price-book ratio of 5.15, a EV-to-Ebitda ratio of -18.36 and a price-sales ratio of 8.94.

Toast Inc


During the quarter, 12 West Capital Management LP bought 2,730,091 shares of NYSE:TOST for a total holding of 3,313,471. The trade had a 3.61% impact on the equity portfolio. During the quarter, the stock traded for an average price of $22.6.

On 05/18/2022, Toast Inc traded for a price of $13.51 per share and a market cap of $6,915,501,000. The stock has returned 0.00% over the past year.

GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 1 out of 10.

In terms of valuation, Toast Inc has a price-book ratio of 6.29, a EV-to-Ebitda ratio of -23.73 and a price-sales ratio of 4.45.

10x Genomics Inc


During the quarter, 12 West Capital Management LP bought 514,500 shares of NAS:TXG for a total holding of 2,518,500. The trade had a 2.38% impact on the equity portfolio. During the quarter, the stock traded for an average price of $87.65.

On 05/18/2022, 10x Genomics Inc traded for a price of $49.46 per share and a market cap of $5,607,375,000. The stock has returned -67.80% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 1 out of 10.

In terms of valuation, 10x Genomics Inc has a price-book ratio of 6.60, a EV-to-Ebitda ratio of -91.11 and a price-sales ratio of 10.50.

The price-to-GF Value ratio is 0.38, earning the stock a GF Value rank of 2.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.

Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles